SAREPTA THERAPEUTICS, INC. (SRPT) FY2026 Q2 Balance Sheet

SAREPTA THERAPEUTICS, INC. (SRPT) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

3,188,512,000 US dollars

Current assets

2,223,824,000 US dollars

Non-current assets

964,688,000 US dollars

Liabilities

1,660,714,000 US dollars

Current liabilities

502,908,000 US dollars

Non-current liabilities

1,157,806,000 US dollars

Equity

1,527,798,000 US dollars

Inventory

904,273,000 US dollars

Cash and cash equivalents

571,148,000 US dollars

Accounts receivable, net

376,824,000 US dollars

Short-term investments

217,341,000 US dollars

Other current assets

105,784,000 US dollars

Manufacturing-related deposits and prepaids

48,454,000 US dollars

Property and equipment, net

325,991,000 US dollars

Non-current inventory

226,333,000 US dollars

Other non-current assets

146,145,000 US dollars

Non-current investments

145,372,000 US dollars

Right of use assets

120,847,000 US dollars

Accrued expenses

325,232,000 US dollars

Deferred revenue, current portion

110,132,000 US dollars

Accounts payable

50,982,000 US dollars

Other current liabilities

16,562,000 US dollars

Long-term debt

847,623,000 US dollars

Lease liabilities, net of current portion

198,226,000 US dollars

Deferred revenue, net of current portion

110,132,000 US dollars

Other non-current liabilities

1,825,000 US dollars

Additional paid-in capital

6,104,530,000 US dollars

Common stock, $0.0001 par value, 198,000,000 shares authorized; 106,279,142 and 105,623,500 issued and outstanding, respectively, at June 30, 2026 and 105,615,096 and 104,964,220 issued and outstanding, respectively, at December 31, 2025

11,000 US dollars

Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and outstanding

0 US dollars

Accumulated deficit

negative 4,550,915,000 US dollars

Treasury stock, at cost, 655,642 and 650,876 shares at March 31, 2026 and December 31, 2025, respectively

negative 25,263,000 US dollars

Accumulated other comprehensive income (loss), net of tax

negative 565,000 US dollars

Gross equity (calculated)

6,104,541,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.